News

Healio19h
‘Encouraging’ findings could spur treatment opportunity for patients with colorectal cancer
An evaluation of nearly 19,000 patients with metastatic colorectal cancer supported clinical trial data that immunotherapy ...
Applied Clinical Trials Online21h
Imfinzi Regimen Demonstrates Positive, Meaningful Outcomes in Phase III Bladder Cancer Trial
In the POTOMAC study, one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance ...
CURE22h
Imfinzi Regimen Improves Disease-Free Survival in Early Bladder Cancer
Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...
Fierce Pharma23h
AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder cancer patients
AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the ...